260 related articles for article (PubMed ID: 16831226)
1. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.
Larkins TL; Nowell M; Singh S; Sanford GL
BMC Cancer; 2006 Jul; 6():181. PubMed ID: 16831226
[TBL] [Abstract][Full Text] [Related]
2. Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor.
Paquette B; Therriault H; Desmarais G; Wagner R; Royer R; Bujold R
Br J Cancer; 2011 Aug; 105(4):534-41. PubMed ID: 21792195
[TBL] [Abstract][Full Text] [Related]
3. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
Rozic JG; Chakraborty C; Lala PK
Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
[TBL] [Abstract][Full Text] [Related]
9. COX-2 overexpression increases motility and invasion of breast cancer cells.
Singh B; Berry JA; Shoher A; Ramakrishnan V; Lucci A
Int J Oncol; 2005 May; 26(5):1393-9. PubMed ID: 15809733
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
Leung E; McArthur D; Morris A; Williams N
Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.
Ko CJ; Lan SW; Lu YC; Cheng TS; Lai PF; Tsai CH; Hsu TW; Lin HY; Shyu HY; Wu SR; Lin HH; Hsiao PW; Chen CH; Huang HP; Lee MS
Oncogene; 2017 Aug; 36(32):4597-4609. PubMed ID: 28368394
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells.
Lee EJ; Choi EM; Kim SR; Park JH; Kim H; Ha KS; Kim YM; Kim SS; Choe M; Kim JI; Han JA
Exp Mol Med; 2007 Aug; 39(4):469-76. PubMed ID: 17934334
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/matrix metalloproteinase-2 pathway.
Liu Y; Zhang W; Zhang X; Qi Y; Huang D; Zhang Y
Exp Biol Med (Maywood); 2011 May; 236(5):592-7. PubMed ID: 21540248
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44.
Kinugasa Y; Hatori M; Ito H; Kurihara Y; Ito D; Nagumo M
Clin Exp Metastasis; 2004; 21(8):737-45. PubMed ID: 16035618
[TBL] [Abstract][Full Text] [Related]
15. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mason MD; Mansel RE
Int J Mol Med; 2006 Apr; 17(4):583-90. PubMed ID: 16525713
[TBL] [Abstract][Full Text] [Related]
16. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
[TBL] [Abstract][Full Text] [Related]
17. Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.
Li M; Li P; Zhang M; Ma F
Chin J Integr Med; 2018 Jan; 24(1):40-46. PubMed ID: 28795388
[TBL] [Abstract][Full Text] [Related]
18. Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.
Xu Y; Yang X; Wang T; Yang L; He YY; Miskimins K; Qian SY
BMC Cancer; 2018 Mar; 18(1):330. PubMed ID: 29587668
[TBL] [Abstract][Full Text] [Related]
19. NDRG2 controls COX-2/PGE₂-mediated breast cancer cell migration and invasion.
Kim MJ; Kim HS; Lee SH; Yang Y; Lee MS; Lim JS
Mol Cells; 2014 Oct; 37(10):759-65. PubMed ID: 25256221
[TBL] [Abstract][Full Text] [Related]
20. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
